Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
modified Xiao Chai Hu Tang (also known as Jiawei Xiao Chaihu Tang or flavored chaihu soup) is a traditional Chinese medicine (TCM) herbal formulation derived from the classic Xiao Chai Hu Tang (Minor Bupleurum Decoction). It is being evaluated in clinical trials, often in combination with antidepressants like duloxetine, for the treatment of cancer-related depression, anxiety, insomnia, and pain. The formulation typically consists of a base of Bupleurum Radix (Chai Hu), Scutellariae Radix (Huang Qin), Pinelliae Rhizoma (Ban Xia), Ginseng Radix (Ren Shen), Glycyrrhizae Radix (Gan Cao), Zingiberis Rhizoma (Sheng Jiang), and Zizyphi Fructus (Da Zao), with additional herbs added to enhance its therapeutic effects on mood, sleep, and inflammation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on modified Xiao Chai Hu Tang.